A/Prof Nicholas Opie is a biomedical engineer with experience in neural prostheses and co-head of the Vascular Bionics Laboratory. He completed his BE (Hons) and BSc undergraduate degrees at Monash University in 2007, his MBA at Melbourne Business School in 2018 and was awarded his PhD in 2012 for research developing a bionic eye. He was employed as the Surgical Program Coordinator on Bionic Vision Australia's retinal prosthesis project, and was integral in development and preclinical validation of the technology designed to restore rudimentary vision to the profoundly blind. This device was implanted in three patients in 2012 with great success. In 2012, A/Prof Opie was awarded a $1.33M grant from US defence organization DARPA to develop a minimally invasive brain machine interface. This funding, and subsequent funding totaling more than $15.5M has enabled Dr Opie to establish and co-lead the Vascular Bionics Laboratory within the Department of Medicine at The University of Melbourne; a laboratory which has grown to support more than 35 graduate and undergraduate researchers. He is leading the research team conducting preclinical safety and efficacy trials on a device capable of recording neural information from within a blood vessel, which may enable direct brain control of wheelchairs, exoskeletons and computers to people with paralysis. Dr Opie is a Founding Director and CTO of Synchron, a company incorporated to translate endovascular bionic technology into clinical application.
Australasian Neuroscience Society (ANS).
Australasian Neuroscience Society (ANS) 2016 -
Institute of Electrical and Electronic Engineers (IEEE).
Institute of Electrical and Electronic Engineers (IEEE) 2012 -
American Association for teh Advancement of Science (AAAS).
American Association for teh Advancement of Science (AAAS) 2010 -
Minimally invasive endovascular neural stimulation (2019-21). Grayden D, John S, Opie N, Oxley T, Freestone D. NHMRC Project Grant (APP1158912). $697,000 Stentrode with Thought Controlled Digital Switch: A first in human early feasibility study of the Stentrode in participants with loss of motor function due to paralysis (2019). Oxley T, Opie N, Morokoff A. NHMRC Project Grant (GNT1161108). $755,528 Feasibility of endovascular cortical stimulation using the Stentrode (2019). Grayden D, John S, Opie N, Oxley T, May C. Victorian Medical Research Acceleration Fund. $450,000 Minimally invasive brain controlled communication (2019). Oxley T, John S, Opie N, Campbell B, Lee S, Wools C. Victorian Medical Research Acceleration Fund. $275,000 Stentrode stimulation for epilepsy (2018-19). Oxley T, Opie N, Grayden D, John. Department of Defense (USA). $250,000 Minimally invasive communication and navigation (2018). Oxley T, Opie N, Grayden D, John S. MND Foundation. $100,000 Stentrode: Preclinical validation of first in man endovascular brain machine interface device (2018-19). Oxley T, Opie N. Office of Naval Research Global (USA, N62909-14-N020). $585,000 Preclinical validation of first in man endovascular brain machine interface device (2017-20). Oxley T, Opie N. NHMRC Development Grant (APP1138110). $870,000 Returning wounded soldiers: Direct brain control of wheelchairs and vehicles (2017-20). Opie N, Oxley T, Burkitt A, Davis S, Grayden D, May C, Mitchell P, O’Brien T, Rind G, John S, Ronayne S. USAMRAA, Department of Defense (USA). $1,508,107 Feasibility of a piezoelectrically powered endovascular neural stimulator (2017-20). Opie N. Westpac Bicentennial Research Fellowship. $571,279 Minimally invasive intravascular device for patients with paralysis (2016-18). Oxley T, Opie N, Meltzer A, Rind G, Ronayne S. Australian Government Accelerating Commercialization. $700,000 Connecting man to machine: Wireless brain machine interface (2015-19). Prawer S, Opie N, Ox